Date: Feb 2022
Advanced Dermatology Drug Delivery Devices Market worth USD 8,783.0 million by 2030
The Market Statsville Group (MSG) publishes the new report on the "Advanced Dermatology Drug Delivery Devices Market by Product Type (Injectors, Patches, Airless Dispensers and Bottles, Dermal Pumps, Valves, and Other Devices), by End-Market (B2B Sales and B2C Sales), by End-Users (Hospitals, Dermatology Practices, and Home Use), by Region – Global Share and Forecast to 2030". The global advanced dermatology drug delivery devices market size is projected to grow at a CAGR of 10.5% to reach USD 8,783.0 million by 2030 from USD 3,569.8 million in 2021. The advanced dermatology drug delivery devices features a highly complex and competitive technological landscape. Technology is one of the primary differentiators in this field. Consequently, companies put a strong emphasis on the development of intellectual property (IP). Adherence is one of the key concerns in the healthcare industry. Key players in the global advanced dermatology drug delivery devices market have been focused on technological developments which can aid in the improvement of adherence. The growth in effective adherence can have a positive impact on patient health. Going forward, drug delivery devices are comprised of various features that will promote adherence. With evolving technologies, the major players in the market are expected to integrate their offerings with connectivity features through apps. For instance, Portal Instruments, Inc. aims to use its injector to log all injections connected with patient apps or physician records. The collected data can provide real-time adherence insights that teams can use to improve adherence.
Global Advanced Dermatology Drug Delivery Devices Market Segmentation
The advanced dermatology drug delivery devices market has been segmented into product type, sales channel, end-users, and region.
By Product Type Outlook (Sales, USD Million, 2017-2030)
- Injectors
- Disposable Injectors
- Reusable Injectors
- Wearable Injectors
- Patches
- Microarray (MAP) Patches
- Microneedle (MNP) Patches
- Solid Removable Microneedles
- Coated Microneedles
- Dissolving Microneedles
- Hollow Microneedles
- Hydrogel-Forming Microneedles
- Needle-less Patches
- Airless Dispensers and Bottles
- Dermal Pumps
- Valves
- Other Devices
By Sales Channel Outlook (Sales, USD Million, 2017-2030)
- B2B Sales (Pharma/Direct)
- B2C Sales (OTC/Indirect)
By End-Users Outlook (Sales, USD Million, 2017-2030)
- Hospitals
- Dermatology Practices
- Home Use
By Region Outlook (Sales, USD Million, 2017-2030)
- North America (US, Canada, Mexico)
- South America (Brazil, Argentina, Colombia, Peru, Rest of Latin America)
- Europe (Germany, Italy, France, UK, Spain, Poland, Russia, Slovenia, Slovakia, Hungary, Czech Republic, Belgium, the Netherlands, Norway, Sweden, Denmark, Rest of Europe)
- Asia Pacific (China, Japan, India, South Korea, Indonesia, Malaysia, Thailand, Vietnam, Myanmar, Cambodia, the Philippines, Singapore, Australia & New Zealand, Rest of Asia Pacific)
- The Middle East & Africa (Saudi Arabia, UAE, South Africa, Northern Africa, Rest of MEA)
B2B, by sales channel, is estimated to hold the largest market share during the forecast period
The global advanced dermatology drug delivery devices market has been segmented based on the sales channel into two segments: business-to-business (B2B) sales channels and business-to-communication (B2C) sales channels. In 2021, B2B sales channel accounted for the largest market share of 90.0%. Manufacturers in the market have been focusing on expanding their network of operations either through technological advancements or business synergies in the healthcare industry. Drug-device combinations are usually sold only through the B2B channel.
B2B sales channel includes the drug delivery devices sold through contract manufacturers or drug delivery device manufacturers selling to pharmaceutical companies. Pharmaceutical and biopharmaceutical companies partner with drug delivery system manufacturers to develop advanced drug delivery devices such as auto-injectors, prefilled syringes, patches, and airless dispensers and bottles. The market includes products such as pumps sold to the prescription drug market for topical applications.
North America accounts for the largest market share
Based on the regions, the global advanced dermatology drug delivery devices market has been segmented across North America, Asia-Pacific, Europe, South America, and the Middle East & Africa. In 2021, North America accounted for the highest market share of 41.4% in the global advanced dermatology drug delivery devices market and was anticipated to maintain its dominance throughout the forecast period. The growth of chronic diseases, rise in the geriatric population, and presence of multiple established companies in the region are the primary propellers for the region’s growth. The North America region is expected to remain the epicenters of innovation in the global advanced dermatology drug delivery devices market during the forecast period 2022-2030.
North America's advanced dermatology drug delivery devices market is expected to be mainly driven by technological development in the healthcare industry, the adoption of connected devices, and increased demand for self-administration. The increasing intensity of competition is expected to impact the North America market during the long term strongly. In terms of market restraining factors, such as data privacy concerns and the stringent regulations associated with the devices, are expected to have a low impact on how the market is expected to grow during the forecast period. North America, advanced dermatology drug delivery devices market is expected to be driven by advancements in communication technologies such as near field communication (NFC), Wi-Fi, Bluetooth low energy (Bluetooth LE), and communication protocols.
The advanced dermatology drug delivery market comprises a wide range of product types. In terms of technological development, most of the growth in the future is expected to be from the sales of connected devices, which will also include new entrants from the software and tech industry. Market players are currently focused on developing a wide range of solutions to enhance medication adherence. Major players in the market are AptarGroup, Inc., Bespak, E3D Elcam Drug Delivery Devices, Kindeva Drug Delivery L.P., Becton Dickinson and Company, Medicsensors S.L, Latch Medical, Midas Pharma GmbH, Nemera, Owen Mumford, Credence MedSystems, Inc., Portal Instruments, Inc., LTS Lohmann Therapie-Systeme AG, Vaxxas Inc., and West Pharmaceutical Services, Inc.
Browse complete report: https://www.marketstatsville.com/advanced-dermatology-drug-delivery-devices-market
About Market Statsville Group
Market Statsville Group (MSG) is a business research and consulting platform of Statsville Consulting Private Limited, based in Oklahoma, USA. MSG is the leading market research and strategy builder with the depth and breadth of solutions that perfectly suit your every need. MSG provides solutions in a wide range of industry verticals in market sizing, analysis, and intelligent business insights. MSG has experienced research analysts who are proficient at digging deep and providing various customizable data that help you make decisions with clarity, confidence, and impact. Furthermore, Market Statsville Group already benefited more than 1,000 companies each year for their revenue planning. It helped them take their disruptions/innovations early to the market by providing them research ahead of the curve.
MSG has an entire repository of research reports on more than 1,000 niche industries, 3,000 high-growth potentials markets, 5,000 data sets, and more than 12,000 company profiles.
Contact Us:
Market Statsville Group
416, East Standsberry Street, Perkins, Oklahoma 74059, USA
USA: +1-580-205-2707 | +91 702 496 8807
Email: sales@marketstatsville.com
$4450
$3338
save 25%
$5850
$4095
save 30%
$8150
$5298
save 35%